Pfizer, Merck trim prices in China for Paxlovid, molnupiravir – reports
SHANGHAI (Reuters) – Pfizer and Merck have slightly lowered the
paxlovid
Paxlovid sales forecasts may change with Pfizer view on China
By Manas Mishra and Michael Erman (Reuters) – Clarity from
Pfizer working to send COVID pill Paxlovid to China – CNBC
(Reuters) – Pfizer Inc is working with Chinese authorities to
U.S. government to test Pfizer’s Paxlovid for long COVID
By Julie Steenhuysen CHICAGO (Reuters) – The U.S. National Institutes
Some long COVID patients still have virus in the blood; Paxlovid rebound patients may need longer treatment
By Nancy Lapid (Reuters) – The following is a summary
U.S. doctors reconsider Pfizer’s Paxlovid for lower-risk COVID patients
By Deena Beasley (Reuters) – Use of Pfizer Inc’s COVID-19
Evidence mounts for need to study Pfizer’s Paxlovid for long COVID – researchers say
By Julie Steenhuysen CHICAGO – Additional reports of patients with
The case for testing Pfizer’s Paxlovid for treating long COVID
By Julie Steenhuysen CHICAGO – Reports of two patients who